PinnyPeptide

Cardiogen vs Thymalin

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Cardiogen

Bioregulators

Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium.

Peptide B

Thymalin

Bioregulators

Original Khavinson thymic peptide complex — multi-peptide immunomodulator with 40-year Russian clinical track record.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

10 mg

Typical dose

5,000-30,000 mcg

Half-life

Variable (peptide complex)

FDA status

Not FDA approved.

Cardiogen effects

  • Reported improvement in myocardial contractility (Russian observational)
  • Possible reduction in age-related cardiac decline
  • Improved exercise tolerance in elderly CAD patients
  • Modulation of cardiac remodeling processes
  • Anti-inflammatory effects in cardiac tissue

Thymalin effects

  • Reported improvement in T-cell numbers (especially CD4+)
  • Improvement in CD4/CD8 ratio
  • Enhanced NK-cell function
  • Reduction in infection rates in immunocompromised patients
  • Long-term observational reduction in mortality (Khavinson 2003 study)
  • Anti-inflammatory effects

Cardiogen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proven cardiac therapies

Thymalin side effects

  • Generally well-tolerated across 40 years of Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Caution in active autoimmune disease

Cardiogen dosing ranges

Cardiac function support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Thymalin dosing ranges

Immune support (Russian clinical)

5-30 mg · Once daily IM or SubQ · 5-10 day course, repeated 2-3 times per year

Full Cardiogen guide → Full Thymalin guide →

Cardiogen vs Thymalin — common questions

What is the difference between Cardiogen and Thymalin?

Cardiogen: Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium. Typical dose 1,000-5,000 mcg. Thymalin: Original Khavinson thymic peptide complex — multi-peptide immunomodulator with 40-year Russian clinical track record. Typical dose 5,000-30,000 mcg. Both fall under the Bioregulators category.

Can you stack Cardiogen and Thymalin?

Stacking Cardiogen with Thymalin is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Cardiogen or Thymalin?

Cardiogen is typically dosed: Once daily (SubQ) or sublingual for Cardiac function support. Thymalin is typically dosed: Once daily IM or SubQ for Immune support (Russian clinical).

Are Cardiogen and Thymalin FDA approved?

Cardiogen: Not FDA approved. Thymalin: Not FDA approved.

Related peptide comparisons

bronchogen vs cardiogencardiogen vs cartalaxcardiogen vs cortagencardiogen vs crystagencardiogen vs ovagencardiogen vs pancragen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free